Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Persistence of Bacterial Vaginosis: The Effects of High Dose Intravaginal Metronidazole

NCT00741845 is registered in ClinicalTrials.gov with Embil Pharmaceutical Co. Ltd as lead sponsor.

NCT NCT00741845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00741845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Persistence of Bacterial Vaginosis: The Effects of High Dose Intravaginal Metronidazole
Lead sponsor
Embil Pharmaceutical Co. Ltd
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2008
Completion date
Not reported
Enrollment
117 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis